Here, the evidence is less favorable
If you do not meet clinical criteria or the provider determines GLP-1 medications are not appropriate for your situation, you will not receive a prescription
On the other hand, Wegovy, or semaglutide 2.4 mg, is a once-weekly injectable medication specifically indicated for chronic weight management in adults with obesity or overweight who have at least one weight-related comorbidity
328,329 Other macromolecules such as oligonucleotides, 330 aptamers, 331 and synthetic glycopolymers 332336 have also been reported, with lipidation introduced by chemical ligation, or using a lipid-containing polymer initiator
Choosing the right method depends on your health goals and lifestyle
These variations can increase the risk of potential safety concerns, including developing serious adverse effects and health risks like kidney and heart disease